- The Myeloma Beacon - https://myelomabeacon.org -
Myeloma, Party Of Two: “May I Have Another?”
By: Tabitha Tow Burns; Published: May 31, 2018 @ 12:57 am | Comments Disabled
Lately, our life reminds me of one of those 80s movies where some fraternity pledge is getting spanked with a wooden paddle, and the wincing recruit says, “Thank you, sir! May I have another?”
My husband, Daniel, has just finished his second cycle of Kyprolis (carfilzomib), Revlimid (lenalidomide), and dexamethasone (Decadron) treatment for his multiple myeloma. He seems to be tolerating the regimen reasonably well, given the side effects that he could be having. However, we already have seen our fair share of challenges, and they are intensifying with each session in the infusion chair.
First and foremost, each week we hope that his blood cell counts will be within acceptable ranges so he can continue with his treatment regimen. Like many cancer patients undergoing treatment, Daniel is on a neutropenic seesaw. Two weeks ago, his absolute neutrophil count and white blood cell count had dropped too low for him to be able to continue treatment. He was given Neupogen (filgrastim) shots and sent home to lay low, avoid the public, wear surgical masks, and practice good hand washing. He lived in a near-sterile bubble until his white blood cell count had a few days to get back to acceptable ranges so that he could resume treatment.
As a caregiver, I’m learning that these treatment cycles are a well-orchestrated symphony of many, many moving parts. Anyone who has ever had to delay their treatment also knows the added stress that comes with rescheduling appointments to be within the correct timelines once something has shifted. In our case, Daniel has his Kyprolis infusions twice a week. The current plan is for him to complete four 28-day cycles, which include 23 days of treatment and five days of rest. After the four cycles are complete, he will have an autologous stem cell transplant, which will probably be in August.
Within his treatment cycle, there are specific days that are designated for different activities. On precisely numbered days within the cycle, he has blood tests and fast-track appointments with myeloma staff to review his test results before treatment infusions. He also has 24-hour urine and full myeloma blood panels that are for his myeloma specialist, once-a-month oncology appointments to check his progress, and appointments with his stem cell transplant specialist to plan for the upcoming transplant.
In addition, there are specific days in each treatment cycle in which he only takes oral medication (no intravenous therapy). On days 22 and 23, he takes five dexamethasone pills that keep him from having to return to the treatment center for dex shots, since he does not receive Kyprolis on these days. On days 24 through 28, he has “rest days” where he only takes supportive medication, such as Valtrex (valacyclovir) to prevent shingles; baby aspirin to prevent blood clots; Zantac (ranitidine) to prevent irritation of the stomach lining; and magnesium and vitamins D and B12, which he takes daily to support blood insufficiencies.
As you can imagine, if you have to delay treatment for any reason, it takes a lot of patience and follow-up phone calls with several departments and schedulers to ensure that all the appointments are occurring in the correct sequence again. Then the next week might bring low platelets or neutrophils or some other issue that causes the cycle to begin all over again.
But the scheduling is the least of it, of course. The danger of being neutropenic is that one is more susceptible to disease, viruses, and harmful bacteria, because one's immunity is dangerously low. We take it very seriously. The last thing we want is for Daniel to end up back in the hospital, as he was before he started treatment, when he was admitted with a fever and infection of unknown origin.
He has other side effects as well, ranging from lower gastrointestinal issues to jaw cramping.
The worst of it, however, is definitely the fatigue. The smallest activities, like being out of the house for a few hours, really take it out of him. He has noticed this fatigue increasing with each week of treatment. Knowing how exhausted he is now that he has completed his second cycle, I wonder what he will feel like during the fourth cycle of treatment, or during his stem cell transplant. I hope that he will ramp up slowly, and not have it hit him like a ton of bricks. I just tell myself that people survive these transplants every day. It will be hard; but he will get through it.
We’re very fortunate that Daniel’s job has arranged a laptop for him and allowed him to work from home, so he can avoid going in to the office when he is not feeling well or shouldn’t be out in public. Oddly enough, he is able to get even more done from home, since he can work at all hours, which comes in handy on those “dex days” when the steroid has him wide awake and unable to sleep at 3:00 am.
Daniel also has a terrible time with his veins blowing, which is particularly nerve-wracking experience given that he gets multiple IV lines inserted each week. He doesn’t have a port yet, so the IV lines have to be inserted in his hands or wrists or wherever the staff can find a vein. He says that it looks much worse than it feels, but I suspect he is only saying that for my benefit. It is hard for me to watch, and on more than one occasion, I have spoken up and asked the nurse to stop because he or she was digging around too long and it didn’t look like they could get the job done.
This brings me to what may be the hardest part of all of this, and that is the emotional strain that all this brings.
No one can really prepare you for the emotional toll that having myeloma or caring for someone with myeloma takes. My husband and I deal with this emotional stress very differently. There’s been more than one occasion where I’ve spoken up – because someone needed to speak up – and he didn’t want me to do so, or he wanted me to handle the situation more like he would have. There have been times when I’ve felt powerless and unappreciated, and there have been times when he has felt powerless and smothered.
Whether you’re a caregiver or a patient, it’s not easy feeling like you have no control. And to be honest, being in control is a luxury that we don’t seem to be afforded these days. Thank goodness we have good communication skills, and we always find a way to talk out the difficulties that treatment is imposing upon us, but what choice do we have? The alternative is to not take the treatment, which of course is no option at all! We know how fortunate he is to be able to receive this treatment!
So it is with this sense of awareness and thankfulness that we approach this time in our lives with equal parts of love and hate: happy that he is getting the life-saving care he needs, and resigned that it is taking its toll.
On the bright side, this won’t last forever. After this fall, induction therapy will be behind us, and by next spring we could be globetrotting like we did when he was smoldering.
For now, we’re like the pledges from the movies. We arrive each week asking, “Thank you, sir! May I have another?”
Tabitha Tow Burns writes a monthly column for The Myeloma Beacon. Her husband Daniel was diagnosed with smoldering myeloma in 2012 after initially being told he had MGUS. You can view a list of her previously published columns here [1].
If you are interested in writing a regular column for The Myeloma Beacon, please contact the Beacon team at .
Article printed from The Myeloma Beacon: https://myelomabeacon.org
URL to article: https://myelomabeacon.org/headline/2018/05/31/myeloma-party-of-two-may-i-have-another/
URLs in this post:
[1] here: https://myelomabeacon.org/author/tabitha-burns/
Click here to print.
Copyright © The Beacon Foundation for Health. All rights reserved.